{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:11:22Z","timestamp":1790806282633,"version":"4.1.0"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA00350 to GK, AA000369 and AA000368 to B.G"],"award-info":[{"award-number":["AA00350 to GK, AA000369 and AA000368 to B.G"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2025,1,29]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endocannabinoids acting via cannabinoid receptor 1 (CB1R) can elicit increased intestinal permeability (a condition also called \u2018leaky gut\u2019). Alcohol binge can adversely affect digestive functions, including intestinal permeability; however, the underlying mechanisms remain incompletely understood. The current study aimed at examining whether CB1R is involved in alcohol binge-induced intestinal permeability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed intestinal epithelial-specific CB1R knockout (CB1\n                      <jats:sup>IEC\u2212\/\u2212<\/jats:sup>\n                      ) mice and evaluated the\n                      <jats:italic>in vivo<\/jats:italic>\n                      contribution of gut CB1R in alcohol binge-induced intestinal permeability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Alcohol binge increased anandamide levels in the proximal small intestine in association with increased intestinal permeability. Radioligand binding and functional assays confirmed that the genetic deletion of intestinal epithelial CB1R did not alter the density or functionality of CB1R in the brain. Additionally, a peripheral CB1R antagonist, (\n                      <jats:italic>S<\/jats:italic>\n                      )-MRI-1891 (INV-202\/monlunabant), exhibited comparable binding affinity to CB1R in brain homogenates. An acute oral administration of (\n                      <jats:italic>S<\/jats:italic>\n                      )-MRI-1891 (3\u2009mg\/kg) reduced alcohol binge-induced intestinal permeability in littermate control CB1\n                      <jats:sup>f\/f<\/jats:sup>\n                      (CB1 floxed\/floxed) mice but had no effect in CB1\n                      <jats:sup>IEC\u2212\/\u2212<\/jats:sup>\n                      mice, underscoring the role of intestinal CB1R in this phenomenon. Mechanistically, we found that alcohol activated intestinal epithelial CB1R-ERK1\/2 pathway with subsequent downregulation of tight junction proteins and reduction in villi length. In addition, targeting intestinal CB1R and downstream ERK1\/2 was able to reverse this process, with subsequent upregulation of tight junction proteins and increased villi length, thus improving gut barrier function. Despite the effects on intestinal permeability, deletion of intestinal CB1R did not significantly affect metabolic parameters and liver disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that alcohol promotes leaky gut via the activation of gut epithelial CB1R and demonstrate that inhibition of CB1R with peripheral-restricted selective CB1R antagonists can prevent alcohol binge-induced intestinal permeability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/egastro-2024-100173","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T13:10:35Z","timestamp":1739365835000},"page":"e100173","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Gut cannabinoid receptor 1 regulates alcohol binge-induced intestinal permeability"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7580-3340","authenticated-orcid":false,"given":"Luca","family":"Maccioni","sequence":"first","affiliation":[{"name":"Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7945-4061","authenticated-orcid":false,"given":"Szabolcs","family":"Dvor\u00e1csk\u00f3","sequence":"additional","affiliation":[{"name":"Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Section on Fibrotic Disorders, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Laboratory of Biomolecular Structure and Pharmacology, HUN-REN Biological Research Centre Szeged, Institute of Biochemistry, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5489-0219","authenticated-orcid":false,"given":"Grzegorz","family":"Godlewski","sequence":"additional","affiliation":[{"name":"Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-7253","authenticated-orcid":false,"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[{"name":"Section on Fibrotic Disorders, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-4619","authenticated-orcid":false,"given":"Malliga R","family":"Iyer","sequence":"additional","affiliation":[{"name":"Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-2972","authenticated-orcid":false,"given":"Bin","family":"Gao","sequence":"additional","affiliation":[{"name":"Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-4976","authenticated-orcid":false,"given":"George","family":"Kunos","sequence":"additional","affiliation":[{"name":"Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"2025081719091159000_3.1.e100173.1","unstructured":"World Health Organization . Global Status Report on Alcohol and Health 2018. Vol 65. 2018."},{"key":"2025081719091159000_3.1.e100173.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43064-x","article-title":"Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease","volume":"14","author":"Ding","year":"2023","journal-title":"Nat Commun"},{"key":"2025081719091159000_3.1.e100173.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2011.00156.x"},{"key":"2025081719091159000_3.1.e100173.4","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100013","article-title":"Alcohol-associated bowel disease: new insights into pathogenesis","volume":"1","author":"Maccioni","year":"2023","journal-title":"eGastroenterology"},{"key":"2025081719091159000_3.1.e100173.5","doi-asserted-by":"crossref","first-page":"G589","DOI":"10.1152\/ajpgi.00245.2020","article-title":"Effects of dietary components on intestinal permeability in health and disease","volume":"319","author":"Khoshbin","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025081719091159000_3.1.e100173.6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"2025081719091159000_3.1.e100173.7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7150\/ijbs.53589","article-title":"A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease","volume":"17","author":"Bruellman","year":"2021","journal-title":"Int J Biol Sci"},{"key":"2025081719091159000_3.1.e100173.8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jcmgh.2022.05.015","article-title":"Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis","volume":"14","author":"Cuddihey","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025081719091159000_3.1.e100173.9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00294.2015"},{"key":"2025081719091159000_3.1.e100173.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704293"},{"key":"2025081719091159000_3.1.e100173.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109115","article-title":"Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors","volume":"9","author":"Fichna","year":"2014","journal-title":"PLoS One"},{"key":"2025081719091159000_3.1.e100173.12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/nu13041214","article-title":"Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity","volume":"13","author":"DiPatrizio","year":"2021","journal-title":"Nutrients"},{"key":"2025081719091159000_3.1.e100173.13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126682","article-title":"Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases","volume":"25","author":"Crowley","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025081719091159000_3.1.e100173.14","doi-asserted-by":"crossref","first-page":"G219","DOI":"10.1152\/ajpgi.00341.2021","article-title":"Role of CB1 receptors in the acute regulation of small intestinal permeability: effects of high-fat diet","volume":"323","author":"Cuddihey","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025081719091159000_3.1.e100173.15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26165089","article-title":"Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia","volume":"26","author":"Santos-Molina","year":"2021","journal-title":"Molecules"},{"key":"2025081719091159000_3.1.e100173.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4576-4"},{"key":"2025081719091159000_3.1.e100173.17","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.cmet.2019.04.012","article-title":"Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis","volume":"29","author":"Godlewski","year":"2019","journal-title":"Cell Metab"},{"key":"2025081719091159000_3.1.e100173.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.05.037"},{"key":"2025081719091159000_3.1.e100173.19","doi-asserted-by":"crossref","first-page":"11985","DOI":"10.1021\/acs.jmedchem.3c00599","article-title":"Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders","volume":"66","author":"Dvor\u00e1csk\u00f3","year":"2023","journal-title":"J Med Chem"},{"key":"2025081719091159000_3.1.e100173.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.12.015"},{"key":"2025081719091159000_3.1.e100173.21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acsptsci.1c00048","article-title":"Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist","volume":"4","author":"Liu","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2025081719091159000_3.1.e100173.22","doi-asserted-by":"crossref","DOI":"10.1038\/srep14953","article-title":"Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue","volume":"5","author":"Godlewski","year":"2015","journal-title":"Sci Rep"},{"key":"2025081719091159000_3.1.e100173.23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1990.258.3.E399"},{"key":"2025081719091159000_3.1.e100173.24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","article-title":"Profiling the human intestinal environment under physiological conditions","volume":"617","author":"Shalon","year":"2023","journal-title":"Nature New Biol"},{"key":"2025081719091159000_3.1.e100173.25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/EBC20190086","article-title":"The endocannabinoid system","volume":"64","author":"Kilaru","year":"2020","journal-title":"Essays Biochem"},{"key":"2025081719091159000_3.1.e100173.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017"},{"key":"2025081719091159000_3.1.e100173.27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcmgh.2022.10.002","article-title":"Ethanol and its Nonoxidative Metabolites Promote Acute Liver Injury by Inducing ER Stress, Adipocyte Death, and Lipolysis","volume":"15","author":"Park","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025081719091159000_3.1.e100173.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.08.002"},{"key":"2025081719091159000_3.1.e100173.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability--a new target for disease prevention and therapy","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"2025081719091159000_3.1.e100173.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.09.001"},{"key":"2025081719091159000_3.1.e100173.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.12.007"},{"key":"2025081719091159000_3.1.e100173.32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.molmet.2017.08.011","article-title":"Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice","volume":"6","author":"Jourdan","year":"2017","journal-title":"Mol Metab"},{"key":"2025081719091159000_3.1.e100173.33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coph.2016.09.001","article-title":"Gut hormone GPCRs: structure, function, drug discovery","volume":"31","author":"Cordom\u00ed","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"2025081719091159000_3.1.e100173.34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00239.2015"},{"key":"2025081719091159000_3.1.e100173.35","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HEP.0000000000000924","article-title":"Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease","volume":"80","author":"Raya Tonetti","year":"2024","journal-title":"Hepatology"},{"key":"2025081719091159000_3.1.e100173.36","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"2025081719091159000_3.1.e100173.37","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.032"},{"key":"2025081719091159000_3.1.e100173.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.06.066"},{"key":"2025081719091159000_3.1.e100173.39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612177114"},{"key":"2025081719091159000_3.1.e100173.40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/can.2016.0001","article-title":"Endocannabinoids in the Gut","volume":"1","author":"DiPatrizio","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"2025081719091159000_3.1.e100173.41","first-page":"134","article-title":"Role of cannabis in inflammatory bowel diseases","volume":"33","author":"Perisetti","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"2025081719091159000_3.1.e100173.42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00704","article-title":"Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity","volume":"10","author":"Argueta","year":"2019","journal-title":"Front Physiol"},{"key":"2025081719091159000_3.1.e100173.43","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601346R"},{"key":"2025081719091159000_3.1.e100173.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.030"},{"key":"2025081719091159000_3.1.e100173.45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","article-title":"The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Sawada","year":"2023","journal-title":"Cell Metab"},{"key":"2025081719091159000_3.1.e100173.46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"2025081719091159000_3.1.e100173.47","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2024-100173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:10:26Z","timestamp":1755483026000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2024-100173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/egastro-2024-100173"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2024-100173","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}